ZA965163B - Novel peptides for use in treatment of t-cell media cartilage destruction in autoimmune diseases - Google Patents

Novel peptides for use in treatment of t-cell media cartilage destruction in autoimmune diseases

Info

Publication number
ZA965163B
ZA965163B ZA965163A ZA965163A ZA965163B ZA 965163 B ZA965163 B ZA 965163B ZA 965163 A ZA965163 A ZA 965163A ZA 965163 A ZA965163 A ZA 965163A ZA 965163 B ZA965163 B ZA 965163B
Authority
ZA
South Africa
Prior art keywords
autoimmune diseases
cartilage destruction
treatment
novel peptides
cell media
Prior art date
Application number
ZA965163A
Other languages
English (en)
Inventor
Gijsbertus Francisc Verheijden
Anna Maria Helen Boots
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ZA965163B publication Critical patent/ZA965163B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4725—Proteoglycans, e.g. aggreccan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA965163A 1995-06-19 1996-06-18 Novel peptides for use in treatment of t-cell media cartilage destruction in autoimmune diseases ZA965163B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95201656 1995-06-19

Publications (1)

Publication Number Publication Date
ZA965163B true ZA965163B (en) 1997-01-23

Family

ID=8220392

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA965163A ZA965163B (en) 1995-06-19 1996-06-18 Novel peptides for use in treatment of t-cell media cartilage destruction in autoimmune diseases

Country Status (21)

Country Link
EP (1) EP0833842B1 (fr)
JP (1) JPH11507919A (fr)
KR (1) KR19990022972A (fr)
CN (1) CN1155617C (fr)
AT (1) ATE185151T1 (fr)
AU (1) AU704942B2 (fr)
BR (1) BR9608626A (fr)
CA (1) CA2221981A1 (fr)
DE (1) DE69604492T2 (fr)
DK (1) DK0833842T3 (fr)
ES (1) ES2139363T3 (fr)
GR (1) GR3031990T3 (fr)
HU (1) HU223275B1 (fr)
IL (1) IL118524A (fr)
MX (1) MX9710508A (fr)
NO (1) NO975968D0 (fr)
NZ (1) NZ311022A (fr)
PL (1) PL185258B1 (fr)
TR (1) TR199701658T1 (fr)
WO (1) WO1997000270A1 (fr)
ZA (1) ZA965163B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
AU773891C (en) 1998-10-23 2005-02-17 Kirin-Amgen Inc. Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
IL132611A0 (en) 1999-10-27 2001-03-19 Yeda Res & Dev Synthetic genes and polypeptides and pharmaceutical compositions comprising them
US20050084967A1 (en) 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
CA3114617A1 (fr) * 2018-11-26 2020-06-04 North Carolina State University Ligands peptidiques pour la capture de proteines de cellules hotes

Also Published As

Publication number Publication date
MX9710508A (es) 1998-03-31
GR3031990T3 (en) 2000-03-31
IL118524A0 (en) 1996-09-12
HUP9802197A3 (en) 1999-06-28
DK0833842T3 (da) 2000-04-03
IL118524A (en) 2004-02-19
CN1155617C (zh) 2004-06-30
EP0833842A1 (fr) 1998-04-08
ATE185151T1 (de) 1999-10-15
PL185258B1 (pl) 2003-04-30
PL324208A1 (en) 1998-05-11
BR9608626A (pt) 1999-06-15
DE69604492T2 (de) 2000-04-13
JPH11507919A (ja) 1999-07-13
KR19990022972A (ko) 1999-03-25
NZ311022A (en) 1999-11-29
HU223275B1 (hu) 2004-04-28
DE69604492D1 (de) 1999-11-04
CA2221981A1 (fr) 1997-01-03
HUP9802197A2 (hu) 1999-02-01
NO975968L (no) 1997-12-18
TR199701658T1 (xx) 1998-06-22
NO975968D0 (no) 1997-12-18
CN1188483A (zh) 1998-07-22
ES2139363T3 (es) 2000-02-01
WO1997000270A1 (fr) 1997-01-03
AU6224696A (en) 1997-01-15
AU704942B2 (en) 1999-05-06
EP0833842B1 (fr) 1999-09-29

Similar Documents

Publication Publication Date Title
ATE183514T1 (de) Peptide des menschlichen proteins p53 zum gebrauch in menschlichen-zytotoxischen-t-zell- antwort-induzierenden kompositionen sowie menschliche p53-protein-spezifische t-lymphocyten
AUPN568095A0 (en) Anti-Galalpha(1,3)Gal antibody binding peptides
MX9602495A (es) Peptidos novedosos derivados de autoantigeno para usarse en inmunoterapia de enfermedades autoinmunes.
DE69616546D1 (de) Vorrichtung zur reinigung und modifizierung von peptiden
NZ332311A (en) Use of autoantigen HC gp-39 and proteins structurally related thereto in immunotherapy of autoimmune diseases particularly rheumatoid arthritis
ATE440141T1 (de) Virales material und mit multipler sklerose assoziierte nukleotidfragmente mit diagnostischen,prophylaktischen und therapeutischen verwendungen
NZ332427A (en) Peptides suitable for use in antigen specific immunosuppressive therapy
ZA965163B (en) Novel peptides for use in treatment of t-cell media cartilage destruction in autoimmune diseases
WO2000005254A3 (fr) Nouveaux peptides utilises en immunotherapie des maladies auto-immunes
DE69428909D1 (de) Für die immun- und cns-therapie nutzbare, neuartige tripeptide
DE69012989D1 (de) Peptiden von retinblastoma gen produkten und antikoerper dagegen.
ECSP993062A (es) Nuevos peptidos para ser usados en una terapia de tolerancia inducida para impedir las alteraciones autoinmunes, en particular, artritis reumatoidea
NZ505580A (en) Method of treating immunodeficiences using neutrokine alpha
AU7235596A (en) Hla-drb1 peptides with specific binding affinity for hla-dq molecules: prevention and treatment of rheumatoid arthritis